Efavirenz

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 65862-106
  • Package NDC 65862-106-09
  • Package NDC 65862-106-10
  • Package NDC 65862-106-30
  • Package NDC 65862-106-90
  • Application number ANDA078064
  • SPL ID a02dd4c8-6159-48b0-a79c-c362f1f4daf9
  • SPL set ID 4c57ad7f-321a-46c8-851a-c895466eb8e1
  • UNII JE6H2O27P8
  • RxCUI 205290
  • RxCUI 205291
  • RxCUI 205292

What the source publishes

Labeler
Aurobindo Pharma Limited
Active ingredients
Efavirenz
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:65862-106_a02dd4c8-6159-48b0-a79c-c362f1f4daf9
{
  "name": "Efavirenz",
  "splId": "a02dd4c8-6159-48b0-a79c-c362f1f4daf9",
  "labels": [
    {
      "setId": "4c57ad7f-321a-46c8-851a-c895466eb8e1",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c57ad7f-321a-46c8-851a-c895466eb8e1",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c57ad7f-321a-46c8-851a-c895466eb8e1"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Aurobindo Pharma Limited",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "9 BLISTER PACK in 1 CARTON (65862-106-09)  / 10 CAPSULE in 1 BLISTER PACK",
      "package_ndc": "65862-106-09",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20171215"
    },
    {
      "sample": false,
      "description": "3 BLISTER PACK in 1 CARTON (65862-106-10)  / 10 CAPSULE in 1 BLISTER PACK",
      "package_ndc": "65862-106-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20171215"
    },
    {
      "sample": false,
      "description": "30 CAPSULE in 1 BOTTLE (65862-106-30)",
      "package_ndc": "65862-106-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20171215"
    },
    {
      "sample": false,
      "description": "90 CAPSULE in 1 BOTTLE (65862-106-90)",
      "package_ndc": "65862-106-90",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20171215"
    }
  ],
  "productId": "65862-106_a02dd4c8-6159-48b0-a79c-c362f1f4daf9",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "65862-106",
  "deaSchedule": null,
  "genericName": "Efavirenz",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "EFAVIRENZ",
      "strength": "200 mg/1"
    }
  ],
  "applicationNumber": "ANDA078064",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20171215",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175463",
      "N0000175460",
      "N0000009948",
      "N0000190118",
      "N0000187064",
      "N0000185504",
      "N0000182140",
      "N0000182141"
    ],
    "unii": [
      "JE6H2O27P8"
    ],
    "rxcui": [
      "205290",
      "205291",
      "205292"
    ],
    "spl_set_id": [
      "4c57ad7f-321a-46c8-851a-c895466eb8e1"
    ],
    "pharm_class_epc": [
      "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
      "Cytochrome P450 3A Inducers [MoA]",
      "Cytochrome P450 2B6 Inducers [MoA]",
      "Cytochrome P450 2C9 Inhibitors [MoA]",
      "Cytochrome P450 2C19 Inhibitors [MoA]",
      "Cytochrome P450 3A4 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Aurobindo Pharma Limited"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:65862-106_a02dd4c8-6159-48b0-a79c-c362f1f4daf9"